About this trial
This study is a retrospective exploratory trial conducted at a single center, aiming to develop and validate a preoperative lymphatic metastasis model for cervical cancer using artificial intelligence deep learning. The model is trained using preoperative imaging and postoperative pathological findings of cervical cancer patients, with the goal of enhancing the accuracy of lymphatic metastasis prediction through preoperative imaging and offering insights for treatment decisions.
Eligibility criteria
Qualifiers
patients with preoperative diagnosis of invasive cervical cancer stage I-III, with any type of pathology, and patients who underwent radical/modified radical cervical cancer surgery + pelvic lymph node dissection in our hospital.
Age ≥18 years old and ≤80 years old
patients with complete preoperative pelvic MRI images and postoperative pathology and clinical data in our hospital
Disqualifiers
Patients during pregnancy or breastfeeding, patients within 42 days of abortion
Patients who have received neoadjuvant chemotherapy or radiotherapy before surgery for this previous cervical cancer
Patients with other malignant tumors within 5 years
Combination of other underlying diseases that may lead to enlarged pelvic lymph nodes
Trial design
Treatments tested in this trial
- Not listed